10X Genomics Inc

NASDAQ TXG

Data sourced from iex and EODHD
Download Data

10X Genomics Inc Cash Flow Statement 2017 - 2023

This table shows the Cash Flow Statement for 10X Genomics Inc going from 2017 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Net Income
M -255 -166 -58 -543 -31 -112 -19
Depreciation and Amortization
M 44 33 28 19 7 4 4
Non-Cash Items (Other)
M 275 2 0 306 0 1 0
Operating Cash Flow
M -15 -34 -21 -218 35 -76 -11
Capital Expenditures
M -50 -132 -101 -38 -43 -7 -4
Net Acquisitions
M - - - - - - -
Other Investing Activities
M - -4 -5 -2 - 0 0
Investing Cash Flow
M - -4 -5 -2 - 0 0
Repayment/Issuance of Debt (Net)
M - -5 -5 -37 -37 19 0
Equity Repurchase (Common, Net)
M - 21 40 506 0 0 0
Dividends Paid
M - - - - - 0 0
Other Financial Activities
M -6 -5 -5 506 15 104 21
Financing Cash Flow
M -6 -5 -5 506 15 104 21
Exchange Rate Adjustment
M - - - - - 0 0
Beginning Cash
M 222 596 689 476 70 48 42
Ending Cash
M 359 227 596 689 476 70 48
Stock-Based Compensation
M 167 137 96 49 13 3 2
Issuance/Purchase of Shares
M - 21 40 506 0 0 0
Capital Stock Change
M - 0 -1 482 411 87 -
Working Capital
M 469 504 637 656 418 74 46
Free Cash Flow
M -65 -165 -123 -256 -8 -83 -14

StockViz Staff

September 19, 2024

Any question? Send us an email